Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
NNMT Inhibitors as a Therapeutic Option for Metabolic Disorders. Journal of Medicinal Chemistry Policarpo, R., et al
Studies in hundreds of participants have found that higher blood levels of 1-methylnicotinamide (a marker related to NNMT activity) correlated with greater NNMT in adipose tissue, and were inversely related to insulin sensitivity
Personalized options aligned with your health and wellness goals
As fat tissue grows and more NNMT is produced, higher amounts of hormones and pro-inflammatory signals are produced that are responsible for weight gain and other chronic diseases such as type 2 diabetes and cardiovascular disease. NNMT is responsible for converting nicotinamide (NA) into 1-methylnicotinamide (1-MNA), which takes it out of the NAD salvage pathway (see the diagram below)
The medication requires once-weekly subcutaneous administration and delivers consistent appetite control alongside blood sugar regulation
Compound Overview 5-Amino-1MQ, chemically known as 5-Amino-1-methylquinolinium, is a synthetic small molecule used in biochemical research exploring enzyme-mediated metabolic pathways
